Posted Dec 22, 2025
Effective January 1, 2026
A printable PDF is available here.
Effective January 1, 2026, the New York State (NYS) Medicaid program, including both Feefor-Service (FFS) and Medicaid Managed Care (MMC) plans, will incorporate the costs of phosphate binders provided during dialysis sessions into the Ambulatory Patient Group (APG) payment.
This change accounts for the acquisition, storage, and dispensing costs of oral phosphate binders provided to patients during dialysis sessions.
This update aligns with the Centers for Medicare & Medicaid Services (CMS) policy change under the Transitional Drug Add-on Payment Adjustment (TDAPA) finalized in the CMS End Stage Renal Disease (ESRD) Prospective Payment System (PPS) Final Rule, published November 12, 2024 (89 Federal Register 98822). CMS now includes oral-only phosphate binders in the ESRD bundled payment, and NYS Medicaid will follow this approach by incorporating these costs into the APG reimbursement.
Questions?
If you have any questions, please contact your Network Account Manager, or call Provider Services at 1-888-801-1660, Monday to Friday, 8:30am-5:30pm.